Skip to content

Author

Martín Lorenzo-García

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Multicenter study of cladribine in relapsing-remitting multiple sclerosis in patients over 50 years.

OBJECTIVE Cladribine is an oral immunomodulatory drug approved for the treatment of relapsing-remitting multiple sclerosis. However, evidence regarding its use in patients over 50 years is limited. The aim of the study was to evaluate the effectiveness and safety of cladribine in patients with relapsing-remitting multi...

M. S. Fortes-González, L. Herrero-Poch, A. Pato-Pato et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.